GT Biopharma Inc (GTBP)
3.30
+0.10
(+3.29%)
USD |
NASDAQ |
May 03, 16:00
3.30
0.00 (0.00%)
After-Hours: 20:00
GT Biopharma Market Cap: 4.556M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 4.411M |
| May 01, 2024 | 4.376M |
| April 30, 2024 | 4.142M |
| April 29, 2024 | 4.290M |
| April 26, 2024 | 4.618M |
| April 25, 2024 | 5.180M |
| April 24, 2024 | 5.039M |
| April 23, 2024 | 5.039M |
| April 22, 2024 | 5.219M |
| April 19, 2024 | 5.094M |
| April 18, 2024 | 5.246M |
| April 17, 2024 | 5.481M |
| April 16, 2024 | 5.108M |
| April 15, 2024 | 5.246M |
| April 12, 2024 | 5.384M |
| April 11, 2024 | 5.522M |
| April 10, 2024 | 5.522M |
| April 09, 2024 | 5.730M |
| April 08, 2024 | 5.633M |
| April 05, 2024 | 5.730M |
| April 04, 2024 | 6.023M |
| April 03, 2024 | 6.420M |
| April 02, 2024 | 5.798M |
| April 01, 2024 | 5.950M |
| March 28, 2024 | 6.116M |
| Date | Value |
|---|---|
| March 27, 2024 | 6.033M |
| March 26, 2024 | 6.075M |
| March 25, 2024 | 6.088M |
| March 22, 2024 | 6.337M |
| March 21, 2024 | 5.260M |
| March 20, 2024 | 5.812M |
| March 19, 2024 | 6.164M |
| March 18, 2024 | 6.088M |
| March 15, 2024 | 6.392M |
| March 14, 2024 | 6.503M |
| March 13, 2024 | 6.309M |
| March 12, 2024 | 7.082M |
| March 11, 2024 | 6.693M |
| March 08, 2024 | 5.964M |
| March 07, 2024 | 6.084M |
| March 06, 2024 | 5.980M |
| March 05, 2024 | 5.937M |
| March 04, 2024 | 6.254M |
| March 01, 2024 | 6.075M |
| February 29, 2024 | 5.826M |
| February 28, 2024 | 5.785M |
| February 27, 2024 | 5.702M |
| February 26, 2024 | 5.453M |
| February 23, 2024 | 5.343M |
| February 22, 2024 | 5.794M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.142M
Minimum
Apr 30 2024
538.37M
Maximum
Jun 02 2021
69.02M
Average
15.54M
Median
Jul 21 2020
Market Cap Benchmarks
| Cutera Inc | 50.70M |
| Outlook Therapeutics Inc | 184.98M |
| 180 Life Sciences Corp | 1.697M |
| Journey Medical Corp | 73.35M |
| NovaBay Pharmaceuticals Inc | 2.739M |
Market Cap Related Metrics
| PS Ratio | 71.30 |
| Price to Book Value | 0.6095 |
| Price | 3.30 |
| Earnings Yield | -169.2% |